Patent ID: 8163495

Claim:
A method for isolating and/or identifying homogenous mesenchymal stem cells from primary tissue, which includes the following steps: a) putting a sample suspension of cells directly obtained from a primary tissue, and including mesenchymal stem cells, in contact with an antibody, humanized form or antigen binding fragment thereof, wherein the antibody is produced from hybridoma cell lines selected from the group consisting of W1C3 (DSM ACC 2816), W7C6 (DSM ACC 2821), W5C4 (DSM ACC 2814), 24D2, 28D4, HEK-3D6 (DSM ACC 2817), W4A5 (DSM ACC 2571), W3D5 (DSM ACC 2815), W5C5 (DSM ACC 2813), 9A3G9 (DSM ACC 2820), 58B1 (DSM ACC 2819), F9-3C2F1 (DSM ACC 2818), and 39D5 (DSM ACC 2930); and b) identifying and/or isolating those cells in the sample to which an antibody from step a), or antigen binding fragment or humanized form thereof have bound, thereby isolating and/or identifying homogenous mesenchymal stem cells.